bibliographicCitation |
den Uil SH, de Wit M, Slebos RJC, Delis-van Diemen PM, Sanders J, Piersma SR, Pham TV, Coupé VMH, Bril H, Stockmann HBAC, Jimenez CR, Meijer GA, Fijneman RJA. Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer. Eur J Cancer. 2021 Feb;144():91–100. doi: 10.1016/j.ejca.2020.10.029. PMID: 33341450. |